CNPAX
Price
$74.40
Change
+$0.08 (+0.11%)
Updated
Jun 2 closing price
Net Assets
164.3B
MLNCX
Price
$26.17
Change
-$0.17 (-0.65%)
Updated
Jun 2 closing price
Net Assets
423.72M
Interact to see
Advertisement

CNPAX vs MLNCX

Header iconCNPAX vs MLNCX Comparison
Open Charts CNPAX vs MLNCXBanner chart's image
CNPAX vs MLNCX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MLNCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and MLNCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 164B vs. MLNCX (424M). CNPAX pays higher dividends than MLNCX: CNPAX (0.95) vs MLNCX (0.00). CNPAX was incepted earlier than MLNCX: CNPAX (24 years) vs MLNCX (10 years). MLNCX (2.08) is less costly to investors than CNPAX (0.74). MLNCX is a more actively managed with annual turnover of: 51.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than MLNCX: CNPAX (250) vs MLNCX (1000). CNPAX annual gain was more profitable for investors over the last year : 13.85 vs. MLNCX (11.09). MLNCX return over 5 years is better than : 43.31 vs. CNPAX (19.97).
CNPAXMLNCXCNPAX / MLNCX
Total Expense Ratio0.742.0836%
Annual Report Gross Expense Ratio0.742.0836%
Fund Existence24 years10 years-
Gain YTD7.2444.400165%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets164B424M38,679%
Annual Yield % from dividends0.950.00-
Returns for 1 year13.8511.09125%
Returns for 3 years44.0573.1860%
Returns for 5 years19.9743.3146%
Returns for 10 years123.05162.6676%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAIN16.010.11
+0.69%
Gladstone Investment Corp
EXFY1.17N/A
+0.43%
Expensify
BEKE17.230.05
+0.29%
KE Holdings
MBIO0.76-0.01
-0.86%
Mustang Bio Inc
HAE66.37-0.85
-1.26%
Haemonetics Corp